Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Dermatology (Basel, Switzerland)
|
November 14, 2023
Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation
Emily K Kozera, Martina Porter, So Yeon Paek, et al.
Journal of Clinical and Translational Science
|
May 21, 2025
Full spectrum town halls for hidradenitis suppurativa: A model for advancing clinician-patient-researcher engagement in clinical and translational research
Anuradha Hashemi-Arend, Michelle A Lowes, John W Frew, et al.
Skin Appendage Disorders
|
August 18, 2022
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
Jonathan W Rick, Devea R De, Terri Shih, et al.
JAMA Dermatology
|
March 10, 2021
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary
John W Frew, Michelle Anne Lowes, Noah Goldfarb, et al.
The British Journal of Dermatology
|
May 23, 2022
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
Hans Christian Ring, Yiqiu Yao, Julia-Tatjana Maul, et al.
The British Journal of Dermatology
|
April 5, 2024
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
Afsaneh Alavi, Errol P Prens, Alexa B Kimball, et al.
Experimental Dermatology
|
June 4, 2021
Target molecules for future hidradenitis suppurativa treatment
Christos C Zouboulis, John W Frew, Evangelos J Giamarellos-Bourboulis, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 10, 2024
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Lindsey Greenlund, Claire Herzog, Zachary Wendland, et al.
Journal of the American Academy of Dermatology
|
October 1, 2013
A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa
Supriya S Venugopal, Wenfei Yan, John W Frew, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Dermatology (Basel, Switzerland)
|
November 14, 2023
Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation
Emily K Kozera, Martina Porter, So Yeon Paek, et al.
Journal of Clinical and Translational Science
|
May 21, 2025
Full spectrum town halls for hidradenitis suppurativa: A model for advancing clinician-patient-researcher engagement in clinical and translational research
Anuradha Hashemi-Arend, Michelle A Lowes, John W Frew, et al.
Skin Appendage Disorders
|
August 18, 2022
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
Jonathan W Rick, Devea R De, Terri Shih, et al.
JAMA Dermatology
|
March 10, 2021
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary
John W Frew, Michelle Anne Lowes, Noah Goldfarb, et al.
The British Journal of Dermatology
|
May 23, 2022
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
Hans Christian Ring, Yiqiu Yao, Julia-Tatjana Maul, et al.
The British Journal of Dermatology
|
April 5, 2024
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
Afsaneh Alavi, Errol P Prens, Alexa B Kimball, et al.
Experimental Dermatology
|
June 4, 2021
Target molecules for future hidradenitis suppurativa treatment
Christos C Zouboulis, John W Frew, Evangelos J Giamarellos-Bourboulis, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 10, 2024
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Lindsey Greenlund, Claire Herzog, Zachary Wendland, et al.
Journal of the American Academy of Dermatology
|
October 1, 2013
A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa
Supriya S Venugopal, Wenfei Yan, John W Frew, et al.
Page
of 10